Sandoz Group Ag reiterated earnings guidance for the full year 2024. For the year, The company reiterates guidance expecting net sales to grow mid-single digit in constant currencies versus prior year .
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.52 CHF | -0.35% | +1.35% | +16.48% |
Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
May. 22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.48% | 15.07B | |
+19.73% | 43.03B | |
+24.03% | 22.7B | |
+24.21% | 14.77B | |
+57.84% | 13.05B | |
-0.05% | 6.79B | |
-13.79% | 6.58B | |
-8.87% | 5.73B | |
+13.42% | 5.5B | |
+5.66% | 4.59B |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Sandoz Group Ag Reiterates Earnings Guidance for the Full Year 2024